Days Inventory is also known as Days Sales of Inventory (DSI). Paion AG's Average Total Inventories for the
six
months ended in Jun. 2023 was $4.29 Mil. Paion AG's Cost of Goods Sold for the
six
months ended in Jun. 2023 was $3.87 Mil.
Hence, Paion AG's Days Inventory for the
six
months ended in Jun. 2023 was 202.30.
The historical rank and industry rank for Paion AG's Days Inventory or its related term are showing as below:
PAIOF's Days Inventory is not ranked *
in the Drug Manufacturers industry.
Industry Median: 162.83 * Ranked among companies with meaningful Days Inventory only.
Paion AG's Days Inventory
declined
from Jun. 2022 (1,308.62) to Jun. 2023 (202.30).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Paion AG's Inventory Turnover for the
six
months ended in Jun. 2023 was 0.90.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Paion AG's Inventory-to-Revenue for the
six
months ended in Jun. 2023 was 0.58.
Paion AG (OTCPK:PAIOF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Paion AG's Inventory Turnover for the
six
months ended in Jun. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Paion AG's Inventory to Revenue for the
six
months ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Paion AG Days Inventory Related Terms
Paion AG Days Inventory Historical Data
* Premium members only.
The historical data trend for Paion AG's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PAIOF vs ZTS, NBIX, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Paion AG's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paion AG Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Paion AG's Days Inventory distribution charts can be found below:
* The bar in red indicates where Paion AG's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paion AG (PAIOF) has a Days Inventory of 202.30 as of Jun. 2023. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Paion AG and its competitors.
Is Paion AG's Days Inventory too high?
Paion AG's current Days Inventory is 202.30. The Drug Manufacturers industry median Days Inventory is 162.83. Paion AG's value of 202.30 is 24.2% above this industry median. Overall, Paion AG has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Paion AG's Days Inventory compare to ZTS and NBIX?
Paion AG's Days Inventory of 202.30 can be compared against companies in the Drug Manufacturers industry. The industry median Days Inventory is 162.83. Paion AG's value of 202.30 is 24.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 162.83, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paion AG's current Days Inventory of 202.30 is 24.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Paion AG and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 162.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paion AG's current Days Inventory is 202.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paion AG stock overvalued right now?
Paion AG (PAIOF) has a current Days Inventory of 202.30. The current Days Inventory is 202.30 and 24.2% above the Drug Manufacturers industry median of 162.83. Paion AG's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Paion AG (PAIOF), the current Days Inventory is 202.30 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Paion AG is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.
10GF Score
Get the complete analysis for PAIOF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PAIOF has been successfully added to your 
